BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 191373)

  • 1. Analysis and description of procedures used in the study of the relationship of herpes simplex virus "non-virion" antigens to certain cancers.
    Tarro G
    IARC Sci Publ (1971); 1975; (11 Pt 2):291-7. PubMed ID: 191373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes simplex virus nuclear nonvirion antigens detected by anticomplement immunofluorescence.
    Tarro G; Giordano GG; Tripodi A; Cerra R; Di Gioia M; Battista A; Smeraglia R
    Tumori; 1976; 62(6):609-14. PubMed ID: 193223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonvirion antigens produced by herpes simplex viruses 1 and 2.
    Tarro G; Sabin AB
    Proc Natl Acad Sci U S A; 1973 Apr; 70(4):1032-6. PubMed ID: 4352219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes simplex-genitalis virus nonvirion antigens and their implication in certain human cancers: unconfirmed.
    Sabin AB
    Proc Natl Acad Sci U S A; 1974 Aug; 71(8):3248-52. PubMed ID: 4370064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of antibody to envelope antigen of herpes simplex virus type 2 among patients with cervical carcinoma and matched controls.
    Feorino PM; Palmer EL
    J Infect Dis; 1973 Jun; 127(6):732-5. PubMed ID: 4350521
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunological reactivity of antisera prepared against the sodium dodecyl sulfate-treated structural polypeptides of adenovirus-associated virus.
    Johnson FB; Blacklow NR; Hoggan MD
    J Virol; 1972 Jun; 9(6):1017-26. PubMed ID: 4338635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes simplex and herpes genitalis viruses in etiology of some human cancers.
    Sabin AB; Tarro G
    Proc Natl Acad Sci U S A; 1973 Nov; 70(11):3225-9. PubMed ID: 4361685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of type-specific antibody to herpes simplex virus type 1 and 2 in human sera by complement-fixation tests.
    Skinner GR; Hartley CH; Whitney JE
    Arch Virol; 1976; 50(4):323-33. PubMed ID: 179502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and efficacy of antiherpes type 1 and 2 subunit vaccines.
    Kavaklova L; Dundarov S; Andonov P; Bakalov B; Dundarova D; Brodvarova I
    Acta Virol; 1986 Sep; 30(5):402-10. PubMed ID: 2878588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reaction of antigens isolated from herpes simplex virus-transformed cells with sera of squamous cell carcinoma patients.
    Notter MF; Docherty JJ
    Cancer Res; 1976 Dec; 36(12):4394-401. PubMed ID: 187320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Early, non-virion" antigens in herpes simplex virus infected tissue culture cells. I. Detection of "early" antigens with complement fixation test.
    Géder L; Váczi L; Gönczöl E; Jeney E; Lehel F
    Acta Microbiol Acad Sci Hung; 1966-1967; 13(4):357-64. PubMed ID: 4292750
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo and in vitro measurements of the relationship of human squamous carcinomas to herpes simplex virus tumor-associated antigens.
    Hollinshead AC; Chretien PB; Lee OB; Tarpley JL; Kerney SE; Silverman NA; Alexander JC
    Cancer Res; 1976 Feb; 36(2 pt 2):821-8. PubMed ID: 56226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virological studies of malignant tumours of the urogenital system.
    Kulcsár G; Dán P; Csata S; Horváth J; Nász I; Verebélyi A; Ongrádi J
    Acta Microbiol Hung; 1983; 30(3-4):199-202. PubMed ID: 6326457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection with herpes-simplex viruses 1 and 2. II.
    Nahmias AJ; Roizman B
    N Engl J Med; 1973 Oct; 289(14):719-25. PubMed ID: 4353782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies against herpes simplex virus in a group of healthy humans without reactions to herpes simplex virus antigens in blasttransformation assays.
    Møller-Larsen A
    J Clin Lab Immunol; 1986 Jul; 20(3):121-7. PubMed ID: 3018253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of herpes simplex antisera with increased type specificity in guinea pigs by antibody suppression.
    Jeansson S; Ericsson H
    Proc Soc Exp Biol Med; 1974 Dec; 147(3):788-94. PubMed ID: 4374703
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunogenic properties of formalin herpes antigen prepared from cell cultures.
    Benda R; Dbalý V
    J Hyg Epidemiol Microbiol Immunol; 1973; 17(2):237-49. PubMed ID: 4354219
    [No Abstract]   [Full Text] [Related]  

  • 18. Herpes simplex virus tumor-associated antigens in cancer patients.
    Tarro G; Di Gioia M; Cocchiara R; Smeraglia R; Giordano GG; Tripodi A
    Tumori; 1976; 62(6):615-22. PubMed ID: 193224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of the nature of herpesvirus-induced tumour-associated antigens induced by herpes simplex virus type 1 and further analysis of their relationship with squamous-cell carcinomas of the head and neck region.
    Hollinshead AC; Chretien PB; Tarpley JL
    IARC Sci Publ (1971); 1975; (11 Pt 2):307-11. PubMed ID: 191376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement-fixing antigens of herpes simplex virus types 1 and 2: reactivity of capsid, envelope, and soluble antigens.
    Martin ML; Palmer EL; Kissling RE
    Infect Immun; 1972 Feb; 5(2):248-54. PubMed ID: 4117881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.